George Spencer-Green, MD, MS, has been appointed chief medical officer, Taiwan Liposome Company, Ltd. Dr. Spencer-Green will serve as a member of the TLC management team and guide the company in its clinical and regulatory activities. Dr. Spencer-Green has more than three decades of clinical medicine and drug development experience. As the prior vice president and clinical head of Pfizer’s biosimilars development program, he led the team that designed and initiated clinical development plans ...